Long-Term Liabilities: Pacific Biosciences of California, Inc. (PACB)

Brandmark of Pacific Biosciences of California, Inc. (PACB)

The current market quotes for Pacific Biosciences (PACB), a company specializing in the development of DNA analysis tools, as visualized below on GURU.Markets, show debt at the level of 0.00. Steady cash flow is driven by consistent demand for equipment and consumables. The high precision of Revio systems ensures pricing power, while the application of these technologies in the agricultural and medical sectors significantly expands the company's market presence.

PACB PacBio: Company Long-Term Debts in the range 07/04/2022 - 10/30/2026

Pacific Biosciences of California (PACB) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price pacb.com|PACB - Price Target Chart
- company stock exchange capitalization indicators:
Market Valuation PacBio|PACB - Enterprise Value
- book capitalization indicators:
Book Value per Share PacBio|PACB - Book Capitalization|Market Cap to Net Assets Ratio pacb.com|PACB - Company Total Assets
- business debt structure and liquidity details:
Total Debt to Capital Coefficient Pacific Biosciences|PACB - Long-Term Debt to Capital|Current Liabilities to Equity PacBio Corp|PACB - Company Aggregate Debts|Debts to Net Assets PacBio|PACB - Company Long-Term Debts|Company Current Liabilities PacBio|Intermediate Coverage Ratio pacb.com
- business earnings and investment ratios data:
PACB - Net Profit
Summary company analytics:PACB pacb.com
Signature product of Pacific Biosciences of California, Inc.

Scaling Revio systems and the expansion of HiFi sequencing require significant capital expenditures in infrastructure. Analyzing the state of the organization's long-term financial debt, the investor assesses the total volume of credit obligations with a maturity of more than one year. The dynamics of this indicator determine the level of debt load and the risk of default when forming regular cash flows. The stability of this metric confirms the resilience of the Pacific Biosciences (PACB) business model in the eyes of the market.

Who Pacific Biosciences competes with

Company Long-Term Debts Tempus Labs TEM|QGEN - Company Long-Term Debt|Long-Term Liabilities IONS|RGEN: Company Long-Term Debts|Avidity Corp (RNA) - Company Long-Term Debts|CRSP (CRISPR Therapeutics AG) - Company Long-Term Debts|Company Long-Term Liabilities genedx.com (WGS)|Company Long-Term Debts RARE|Long-Term Debt Volume Beam Therapeutics Inc|Company Long-Term Debts SRPT (Sarepta Therapeutics Inc)|TWST (Twist Bioscience Corp) - Long-Term Liabilities|10x Genomics, Inc. - Company Long-Term Debts|Long-Term Debt Volume intelliatx.com NTLA|STOK: Company Long-Term Debts|Company Long-Term Liabilities BioLife Solutions Inc|Company Long-Term Liabilities WVE|MAZE: Company Long-Term Loans and Borrowings|Company Long-Term Debts SION|Company Long-Term Debt PRME (primemedicine.com)|Company Long-Term Debts TSHA (Taysha Gene Therapies, Inc.)|Long-Term Debt Volume uniQure NV (QURE)|MGTX - Company Long-Term Debt|Long-Term Debt REGENXBIO Corp|Solid Biosciences Inc. (SLDB) - Company Long-Term Debt|OCGN - Long-Term Debt Volume|BNTC (Benitec Biopharma) - Company Long-Term Debts|Company Long-Term Liabilities Design Therapeutics Inc (DSGN)|Company Long-Term Debts RCKT|Long-Term Debt Volume 4D Molecular Corp|Company Long-Term Debts LXEO (Lexeo Therapeutics, Inc.)|Korro Bio Inc. (KRRO) - Long-Term Debt|EDIT - Company Long-Term Debt|SLN (Silence Therapeutics PLC) - Company Long-Term Indebtedness|PRQR: Company Long-Term Debts|Company Long-Term Liabilities Codexis|SGMO (Sangamo Therapeutics) - Company Long-Term Debts|Long-Term Debt Nautilus Biotechnology Inc NAUT|Company Long-Term Debt Metagenomi (MGX)|Long-Term Debt Volume Precision BioSciences Inc.|Company Long-Term Debt Generation Bio GBIO|BOLD (Boundless Bio Inc) - Long-Term Liabilities|Exicure Corp - Company Long-Term Debts|IMNN - Company Long-Term Debts|PHIO: Company Long-Term Debts|Company Long-Term Liabilities Mustang Bio|RNAZ (TransCode Therapeutics Inc.) - Company Long-Term Debts|Company Long-Term Debt BNGO|Company Long-Term Debts APDN|bluebirdbio.com - Company Long-Term Indebtedness|Company Long-Term Debt ImmunoPrecise Antibodies Ltd. IPA|OMGA: Company Long-Term Indebtedness|Singular Genomics Systems Inc - Company Long-Term Debts|RGLS - Company Long-Term Debts|Syros Pharmaceuticals (SYRS) - Company Long-Term Debt|Long-Term Liabilities TBIO (telesisbio.com)|TCON (TRACON Pharmaceuticals, Inc.) - Company Long-Term Debts|Company Long-Term Debts Unity Biotechnology Inc.